bims-ciryme Biomed News
on Circadian rhythms and metabolism
Issue of 2025–11–09
two papers selected by
Gabriela Da Silva Xavier, University of Birmingham



  1. J Cell Biol. 2025 Dec 01. pii: e202501221. [Epub ahead of print]224(12):
      Circadian clocks orchestrate the daily rhythms of physiological functions. The underlying mechanisms of circadian clocks are highly conserved across species, driven by endogenous transcriptional-translational feedback loops. CLOCK, a central transcription factor in circadian regulation, requires coregulatory factors and histone modification dynamics to regulate downstream clock-controlled gene expression. In this study, we identify the Drosophila polymerase-associated factor 1 complex (Paf1C) as a previously unrecognized regulator of the circadian transcriptional machinery. We found that knocking down different subunits of Paf1C in pacemaker neurons lengthens the circadian locomotion period. Specifically, downregulation of rtf1, a core subunit of Paf1C, significantly dampens the amplitude of circadian rhythms and extends the locomotor period. This effect is primarily attributed to a reduction in the pacemaker protein PERIOD (PER), mediated through decreased per transcription. Indeed, the overexpression of per in pacemaker neurons rescues the circadian defects caused by rtf1 downregulation. Mechanistically, we identified that rtf1 enhances CLK-mediated per transcription activation. RTF1 physically interacts with CLK, thus promoting its occupancy on the promoters of per and other clock genes. Furthermore, the H3K4me3 methyltransferase SET1 forms complex with CLK and RTF1, facilitates their interaction, and thereby increases H3K4me3 levels at the per/tim promoter to promote their expression. Notably, we discovered that human RTF1 physically interacts with BMAL1/CLOCK and affects the circadian rhythms in U2OS cells, indicating a potentially conserved mechanism in mammals. Together, our results demonstrate that RTF1 regulates circadian rhythms by modulating CLK occupancy and H3K4me3 levels at pacemaker gene promoters.
    DOI:  https://doi.org/10.1083/jcb.202501221
  2. Nat Commun. 2025 Nov 06. 16(1): 9812
      The human circadian clock integrates external environmental changes and internal physiological signals to generate natural oscillations of secreted endocrine signals to regulate diverse biological processes. Here, we explore human receptors responsive to molecules displaying in vivo oscillatory patterns and identify melatonin receptor 1A (MTNR1A) as a promising molecular sensor to trigger transgene expression. We engineer a melatonin-inducible gene switch consisting of ectopically expressed MTNR1A linked to an amplifier module utilizing the native Gαs protein-mediated cell signaling cascade, which involves adenylyl cyclase, cAMP, protein kinase A and the cAMP-responsive transcription factor CREB, to drive transgene expression from a synthetic promoter. This system operates within the physiological melatonin concentration range, selectively responding to night-phase levels of the diurnal rhythm, while remaining unresponsive to day-phase levels. Such temporal control suggests its potential for personalized cell- and gene-based therapies requiring once-per-day dosing regimen. As proof-of-concept, we show that alginate-encapsulated engineered cells implanted in C3H/HeJ male mice can translate circadian inputs or clinically licensed MTNR1A agonists into regulated GLP-1 expression as a therapeutic output exclusively secreted during nighttime, highlighting potential as an experimental cell therapy for obesity-dependent type-2 diabetes.
    DOI:  https://doi.org/10.1038/s41467-025-64761-9